Northwestern Events Calendar


Key Ingredients for Successful Biopharma Partnering Discussions

recurring see all events in this series

When: Friday, February 19, 2021
10:00 AM - 10:45 AM CT

Where: Online
Webcast Link

Audience: Faculty/Staff - Post Docs/Docs - Graduate Students

Contact: Sonia Kim   (847) 467-0446

Group: Innovation and New Ventures Office

Category: Training


How do I position my project for success in partnering and/or licensing?

Please join us for the fifth and final seminar during which Niels Emmerich (VP and Global Head of Search and Evaluation, Abbvie) will share his insight into having a successful partnering/licensing discussion with large biopharma companies. In addition to discussing various entry points (from early stage projects to those that are IND-enabled or in Phase I Clinical Trials), Dr. Emmerich will share some strategic considerations from both the start-up & Big Pharma perspectives. He will provide his insight on what data and information Big Pharma is looking for at different stages along the R&D continuum, and will offer some practical "Do’s and Don’t’s" in the process.

This seminar is part of the INVOForward Therapeutics lecture series focused on helping Northwestern researchers gain insight into how to build a compelling therapeutic data package. While the INVOForward mentorship program has four select faculty-led teams participating, the lectures are open to Northwestern Faculty, Post-docs and Students.

Other INVOForward lectures may be found here.



Niels Emmerich, Ph.D.

Niels Emmerich is VP and Global Head of Search & Evaluation at AbbVie (ABBV). In his role, Niels and his team are responsible for identifying and assessing partnering and investment opportunities. Recent (2020) transactions that the Corporate Strategy Office and the S&E team were able to secure for AbbVie include new partnerships with I-Mab, Genmab, Jacobio, Alpine Immune Sciences, Sosei-Heptares, Frontier Medicines, and others.

Prior to joining the Corporate Strategy Office and S&E, Niels held several other positions at AbbVie and Abbott, and before that with BioPheresis, immatics (co-founder, NASDAQ: IMTX), and McKinsey & Company.


INVOForward Therapeutics is a 6-week Northwestern mentorship program designed to accelerate biomedical commercialization at the university.

If you have any questions, please email

Register More Info Add to Calendar

Add Event To My Group:

Please sign-in